發(fā)布時(shí)間：2019-01-12 12:36

【摘要】：本研究?jī)?nèi)容分為兩個(gè)部分,分別探討犬的改良劍突下經(jīng)皮心包穿刺術(shù)的可行性和安全性以及經(jīng)房間隔穿刺途徑消融室壁瘤相關(guān)室性心動(dòng)過速的有效性和安全性。這兩部分研究分別從改良技術(shù)和優(yōu)化消融策略兩個(gè)方面來(lái)指導(dǎo)難治性室性心律失常的導(dǎo)管消融,為提高手術(shù)療效和安全性,降低操作相關(guān)并發(fā)癥的發(fā)生率等提供了新的思路。第一部分為動(dòng)物實(shí)驗(yàn),通過與常規(guī)的心包穿刺針(Tuohy斜面針)比較,評(píng)估改良的心包穿刺針在犬模型中行劍突下經(jīng)皮心包穿刺術(shù)的可行性和安全性,實(shí)驗(yàn)分為改良的心包穿刺針組和Tuohy針組。第二部分為臨床研究,資料來(lái)源于中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院,共入選5例室壁瘤相關(guān)室速患者,經(jīng)主動(dòng)脈逆行法導(dǎo)管消融失敗后,評(píng)估通過房間隔穿刺途徑消融室速的有效性和安全性。第一部分:犬的改良劍突下經(jīng)皮心包穿刺術(shù)的可行性和安全性研究目的:通過與常規(guī)的心包穿刺針(Tuohy斜面針)比較,探討應(yīng)用改良的心包穿刺針行劍突下經(jīng)皮心包穿刺術(shù)的可行性和安全性。方法:成年雜交犬10只,隨機(jī)分為改良的心包穿刺針組和Tuohy針組。由三位獨(dú)立的研究者(分別達(dá)到高、中和初級(jí)電生理介入手術(shù)水平)進(jìn)行劍突下經(jīng)皮心包穿刺操作,且三位研究者既往均無(wú)使用改良心包穿刺針的經(jīng)驗(yàn)。每位研究者分別嘗試經(jīng)前路和后路兩種方法,每種方法分別進(jìn)行兩次嘗試。通過導(dǎo)絲走形和心包腔造影來(lái)判斷心包穿刺操作是否成功。操作完成后即刻處死,觀察心臟及鄰近組織臟器情況。分別記錄進(jìn)針深度和角度及操作相關(guān)并發(fā)癥的發(fā)生情況。結(jié)果:改良的心包穿刺針組中,前路法進(jìn)針角度平均為27.2±5.52°,而后路法進(jìn)針角度明顯大于前者,平均為68.0±7.26°(P0.01)。而進(jìn)針深度兩種方法并無(wú)顯著性差異,前路法進(jìn)針深度平均為69.3±11.87mm,后路法進(jìn)針深度平均為74.3±10.89mm(P=0.094)。與改良的心包穿刺針組相比,Tuohy針組的并發(fā)癥發(fā)生率相對(duì)較高,但并無(wú)統(tǒng)計(jì)學(xué)差異。Tuohy針組發(fā)生不經(jīng)意穿刺到心肌組織的發(fā)生率為10%,改良穿刺針組為5%(P=0.491);Tuohy針組發(fā)生一例肺損傷;改良的心包穿刺針組發(fā)生一例局部冠狀血管損傷,造成局限性的出血。結(jié)論:與常規(guī)的心包穿刺針Tuohy針相比,改良的心包穿刺針是一種安全、有效的進(jìn)行劍突下經(jīng)皮心包穿刺術(shù)的工具,其操作相關(guān)的并發(fā)癥發(fā)生率相對(duì)更低。第二部分:經(jīng)房間隔穿刺途徑消融室壁瘤相關(guān)室性心動(dòng)過速目的:本研究旨在評(píng)估經(jīng)主動(dòng)脈逆行法導(dǎo)管消融失敗的室壁瘤相關(guān)室性心動(dòng)過速患者,通過房間隔穿刺途徑消融室速的有效性和安全性。方法:自2011年4月至2015年10月在中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院入選室壁瘤相關(guān)室性心動(dòng)過速患者共5例,常規(guī)經(jīng)主動(dòng)脈逆行法導(dǎo)管消融失敗后,應(yīng)用可控導(dǎo)管鞘經(jīng)房間隔穿刺途徑實(shí)施三維電解剖標(biāo)測(cè)并進(jìn)行導(dǎo)管消融治療。收集患者基線資料。術(shù)后隨訪12月。有效性終點(diǎn)為導(dǎo)管消融成功,室速不能被誘發(fā);安全性終點(diǎn)為術(shù)后無(wú)手術(shù)相關(guān)并發(fā)癥。結(jié)果:5例患者中,4例為心尖部巨大室壁瘤,1例為左室間隔后基底部室壁瘤。2例患者外周動(dòng)脈嚴(yán)重狹窄或閉塞,經(jīng)主動(dòng)脈逆行法失敗。余3例患者經(jīng)主動(dòng)脈逆行法均未標(biāo)測(cè)到理想靶點(diǎn)。應(yīng)用可控導(dǎo)管鞘經(jīng)房間隔穿刺途徑行室速導(dǎo)管消融,均達(dá)到導(dǎo)管消融終點(diǎn),無(wú)并發(fā)癥發(fā)生。術(shù)后平均隨訪12(6-16)月,1例患者室速?gòu)?fù)發(fā),再次穿刺房間隔后室速導(dǎo)管消融成功。結(jié)論:經(jīng)房間隔穿刺途徑進(jìn)行左室心律失常導(dǎo)管消融是經(jīng)主動(dòng)脈逆行法的重要補(bǔ)充,應(yīng)用可控導(dǎo)管鞘穿刺房間隔消融室壁瘤相關(guān)室性心動(dòng)過速是安全有效的。
[Abstract]:This study is divided into two parts. The feasibility and safety of pericardiocentesis and the effectiveness and safety of transseptal puncture are discussed. This two part studies the catheter ablation of refractory ventricular arrhythmia from two aspects of improved technique and optimized ablation strategy, and provides a new way to improve the efficacy and safety of the operation and to reduce the incidence of operation-related complications. The first part was animal experiment, and the feasibility and safety of the modified pericardiocentesis was evaluated by comparing with the conventional pericardial puncture needle (Tuohy inclined needle). The experiment was divided into the modified pericardiocentesis needle group and the Tuohy needle group. The second part is a clinical study, which is derived from the Fuwai Hospital of the Chinese Academy of Medical Sciences. Part One: The feasibility and safety of pericardiocentesis under the modified sword process of canines: the feasibility and safety of pericardiocentesis with improved pericardiocentesis was discussed by comparing with the conventional pericardial puncture needle (Tuohy bevel needle). Methods: 10 adult hybrid dogs were randomly divided into modified pericardiocentesis needle and Tuohy needle. The pericardiocentesis was performed by three independent investigators (high, medium and primary electrophysiological interventions, respectively), and none of the three investigators had previously used the modified pericardiocentesis needle. Each investigator tried both anterior and posterior approaches, each of which was attempted twice, respectively. Whether the pericardiocentesis was successful was determined by wire guide and pericardiocentesis. The operation was completed immediately, and the organs of the heart and the adjacent tissues were observed. The depth and angle of the needle and the occurrence of the related complications were recorded separately. Results: In the modified pericardiocentesis needle group, the angle of the needle in the anterior approach was 27. 2 and 5.52 擄, and the angle of the needle in the posterior approach was significantly greater than that of the former, with an average of 68. 0 and 7.26 擄 (P0.01). There was no significant difference in the depth of the needle entering the needle. The average depth of the needle in the anterior approach was 69. 3/ 11. 87mm, and the depth of the needle in the posterior method was 74.3 and 10.89mm (P = 0.094). The incidence of complications in the Tuohy needle group was relatively high compared to the modified pericardial puncture group, but there was no statistical difference. The incidence rate of the tuohy needle group was 10%, the modified puncture needle group was 5% (P = 0.491), the Tuohy needle group had one lung injury, and the modified pericardiocentesis needle group had a partial coronary artery injury, which caused the limited bleeding. Conclusion: Compared with the conventional pericardial puncture needle Tuohy needle, the modified pericardiocentesis needle is a safe and effective tool for pericardiocentesis under the sword process, and the complication rate associated with its operation is relatively low. Part 2: Radiofrequency Catheter Ablation of Ventricular Tachycardia-related Ventricular Tachycardia: The purpose of this study is to assess the effectiveness and safety of ventricular tachycardia in patients with chamber-wall-aneurysm-associated ventricular tachycardia, which has failed by the procedure of transseptal puncture. Methods: From April 2011 to October 2015, a total of 5 patients with ventricular tachycardia were selected from Fuwai Hospital of the Chinese Academy of Medical Sciences, and after the failure of the conventional aortic retrograde catheter ablation, The three-dimensional electroanatomic mapping was performed by the transseptal puncture of the controlled catheter, and the catheter ablation was performed. Collect patient baseline data. The postoperative follow-up was 12 months. The efficacy endpoint was the success of the catheter ablation and the chamber speed could not be induced; the safety endpoint was the post-operative, non-surgical-related complication. Results: Of the 5 patients, 4 cases were the giant cell wall tumor of the apical part, and one case was the wall tumor of the basal bottom of the left ventricular septum. The ideal target point was not detected by the retrograde method of the aortic retrograde method in the remaining 3 patients. The catheter ablation of the catheter was performed by transseptal puncture with the controlled catheter, and the end of catheter ablation was achieved without complication. After the mean follow-up of 12 (6-16) months, 1 patient had a recurrence of room speed, and the ventricular tachycardia after transseptal re-puncture was successful. Conclusion: The ablation of the left ventricular arrhythmia catheter by transseptal puncture is an important supplement to the retrograde approach of the aorta.
【學(xué)位授予單位】：北京協(xié)和醫(yī)學(xué)院
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2017
【分類號(hào)】：R541.7

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 蔣晨陽(yáng);;導(dǎo)管消融的若干種不同能源[J];心電學(xué)雜志;2008年02期

2 ;房顫導(dǎo)管消融研究再獲新成果[J];現(xiàn)代醫(yī)院;2010年12期

3 謝紅英;賴曉芳;方敬;王風(fēng)珍;陳秀珍;;老年人陣發(fā)性室上性心動(dòng)過速的導(dǎo)管消融的圍術(shù)期護(hù)理[J];贛南醫(yī)學(xué)院學(xué)報(bào);2006年06期

4 黃偉民;導(dǎo)管消融程序的準(zhǔn)則[J];國(guó)外醫(yī)學(xué).心血管疾病分冊(cè);1996年04期

5 郭睿;黃晶;;肥厚型梗阻性心肌病導(dǎo)管消融新技術(shù)研究進(jìn)展[J];心血管病學(xué)進(jìn)展;2010年06期

6 陳大年,沈王芳;導(dǎo)管消融房顫的作用[J];心血管病學(xué)進(jìn)展;1998年02期

7 劉興鵬,馬長(zhǎng)生;導(dǎo)管消融所致肺靜脈狹窄的研究進(jìn)展[J];中國(guó)介入心臟病學(xué)雜志;2003年04期

8 姚焰;;惡性室性心律失常導(dǎo)管消融現(xiàn)狀[J];中華實(shí)用診斷與治療雜志;2010年06期

9 董軍;超聲導(dǎo)管消融的應(yīng)用前景[J];國(guó)外醫(yī)學(xué).心血管疾病分冊(cè);1998年01期

10 Sacher F.;Monahan K.H.;Thomas S.P. ;馬超;;房顫導(dǎo)管消融后膈神經(jīng)損傷的特征及結(jié)局:一項(xiàng)多中心研究[J];世界核心醫(yī)學(xué)期刊文摘(心臟病學(xué)分冊(cè));2006年11期

相關(guān)會(huì)議論文 前10條

1 馬長(zhǎng)生;;房顫導(dǎo)管消融適應(yīng)證的選擇[A];寧夏心血管病學(xué)進(jìn)展暨第二屆心血管病介入治療研討會(huì)資料匯編[C];2005年

2 楊德彥;高鵬;鄧華;程康安;陳太波;程中偉;陸曹杰;方全;;個(gè)體化導(dǎo)管消融策略治療陣發(fā)性心房顫動(dòng)的臨床效果[A];中華醫(yī)學(xué)會(huì)心電生理和起搏分會(huì)第十次全國(guó)學(xué)術(shù)年會(huì)會(huì)議匯編[C];2012年

3 賈俊格;;心房纖顫導(dǎo)管消融患者出院后實(shí)施電話隨訪健康教育的體會(huì)[A];2013年河南省介入診療技術(shù)規(guī)范化護(hù)理管理培訓(xùn)班暨學(xué)術(shù)會(huì)議論文集[C];2013年

4 蔣晨陽(yáng);王建安;趙林水;陳冬冬;馬金琦;;導(dǎo)管消融心外膜旁路參與的房室折返型心動(dòng)過速一例[A];2004年浙江省心血管病學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2004年

5 儲(chǔ)慧民;陳曉敏;杜為平;何斌;葉紅華;王勝煌;潘偉民;張福興;劉少穩(wěn);;單點(diǎn)標(biāo)記三維CT融合策略在電解剖標(biāo)測(cè)指導(dǎo)下房顫導(dǎo)管消融中的應(yīng)用[A];2006年浙江省心血管病學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2006年

6 杜丹;王祖祿;梁延春;韓雅鈴;趙寧;張大鵬;趙維龍;梁明;;鹽水灌注導(dǎo)管消融心房顫動(dòng)時(shí)組織爆裂導(dǎo)致急性心臟壓塞三例[A];中華醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì)第十次全國(guó)心血管病學(xué)術(shù)會(huì)議匯編[C];2008年

7 王祖祿;杜丹;梁延春;韓雅鈴;趙寧;張大鵬;趙維龍;梁明;;鹽水灌注導(dǎo)管消融心房顫動(dòng)時(shí)組織爆裂導(dǎo)致急性心臟壓塞三例[A];中華醫(yī)學(xué)會(huì)心電生理和起搏分會(huì)第八次全國(guó)學(xué)術(shù)年會(huì)論文集[C];2008年

8 董玉梅;李學(xué)奇;劉曉霞;楊慶輝;曹雪;;起源于房室瓣環(huán)的室性早搏的導(dǎo)管消融[A];中華醫(yī)學(xué)會(huì)心電生理和起搏分會(huì)第十次全國(guó)學(xué)術(shù)年會(huì)會(huì)議匯編[C];2012年

9 賈俊格;秦延平;王素芳;;心房纖顫導(dǎo)管消融患者出院后實(shí)施電話隨訪健康教育的體會(huì)[A];2011年河南省內(nèi)科護(hù)理新業(yè)務(wù)、新技術(shù)及康復(fù)護(hù)理新進(jìn)展研討會(huì)論文集[C];2011年

10 賈俊格;秦延平;王素芳;;心房纖顫導(dǎo)管消融患者出院后實(shí)施電話隨訪健康教育的體會(huì)[A];2011年河南省介入護(hù)理學(xué)術(shù)交流及高級(jí)研修班論文集[C];2011年

相關(guān)重要報(bào)紙文章 前10條

1 馬長(zhǎng)生;房顫導(dǎo)管消融步入一線治療應(yīng)特別關(guān)注安全性[N];保健時(shí)報(bào);2005年

2 駐京記者　 孫書博;專家呼吁重視房顫導(dǎo)管消融[N];醫(yī)藥經(jīng)濟(jì)報(bào);2006年

3 本報(bào)記者 彭鑫;導(dǎo)管消融或可作為一線治療[N];醫(yī)藥經(jīng)濟(jì)報(bào);2010年

4 本報(bào)記者 韓霽;讓更多心臟病患者獲得康復(fù)的機(jī)會(huì)[N];經(jīng)濟(jì)日?qǐng)?bào);2011年

5 記者 李天舒;冷凍球囊導(dǎo)管消融房顫術(shù)獲成功[N];健康報(bào);2012年

6 本報(bào)記者 楚燕　通訊員 付磊;導(dǎo)管消融開啟房顫治療新時(shí)代[N];廈門日?qǐng)?bào);2009年

7 本報(bào)記者 王輝;導(dǎo)管消融及早根治房顫[N];健康時(shí)報(bào);2004年

8 阿勝　編譯;治療房顫：導(dǎo)管消融療效比藥物更好[N];醫(yī)藥經(jīng)濟(jì)報(bào);2010年

9 劉錫潼;房顫消融成功率已達(dá)80%[N];北京商報(bào);2006年

10 健康時(shí)報(bào)記者 韋川南;首例冷凍球囊導(dǎo)管消融房顫術(shù)完成[N];健康時(shí)報(bào);2012年

相關(guān)博士學(xué)位論文 前1條

1 陳戀;難治性室性心律失常導(dǎo)管消融改良技術(shù)的初步探索性研究[D];北京協(xié)和醫(yī)學(xué)院;2017年

相關(guān)碩士學(xué)位論文 前7條

1 余香;口服抗凝藥在房顫導(dǎo)管消融圍手術(shù)期應(yīng)用進(jìn)展[D];重慶醫(yī)科大學(xué);2015年

2 賴正剛;兩代冷凍球囊房顫導(dǎo)管消融療效及安全性對(duì)比Meta分析[D];重慶醫(yī)科大學(xué);2016年

3 江峰;FTI聯(lián)合VisiTag指導(dǎo)陣發(fā)性心房顫動(dòng)導(dǎo)管消融療效和安全性研究[D];大連醫(yī)科大學(xué);2017年

4 曹中靜;特發(fā)性室性心律失常的左心功能變化及導(dǎo)管消融臨床療效評(píng)價(jià)[D];第三軍醫(yī)大學(xué);2014年

5 孫偉;新型與傳統(tǒng)三維電解剖標(biāo)測(cè)系統(tǒng)對(duì)心房顫動(dòng)導(dǎo)管消融手術(shù)影響的對(duì)照研究[D];大連醫(yī)科大學(xué);2013年

6 蔣晨曦;CARTO系統(tǒng)引導(dǎo)下房顫導(dǎo)管消融13例分析并文獻(xiàn)綜述[D];中國(guó)協(xié)和醫(yī)科大學(xué);2007年

7 蔣周芩;影響導(dǎo)管射頻消融術(shù)治療心房顫動(dòng)臨床療效的相關(guān)因素評(píng)估[D];第三軍醫(yī)大學(xué);2014年

，

本文編號(hào)：2407781